Orally Dissolving Film-Based Influenza Vaccines Confer Superior Protection Compared to the Oral Administration of Inactivated Influenza Virus
Open Access
Abstract
Background: Self-administered orally dissolving films (ODFs) encapsulating inactivated influenza vaccines represent an effective strategy for stimulating mucosal immunity. While this vaccination method offers several advantages over conventional influenza vaccines, a comparative efficacy study remains lacking. Methods: Female BALB/c mice were immunized with inactivated A/PR/8/34 (H1N1) either via orogastric inoculation or through the oral mucosal delivery using pullulan and trehalose-based ODF vaccines. Each group received equivalent antigen doses across three immunizations. Humoral responses and antibody functionality were assessed using sera collected post-immunization. After lethal viral challenge, other immunological and virological parameters were determined in corresponding tissues. Body weight and survival were monitored over a 14-day period after challenge. Results: ODF vaccination elicited significantly higher virus-specific IgA levels, HAI titers, and neutralizing antibody activity than oral gavage. After the viral challenge, ODF-immunized mice exhibited stronger IgG and IgA responses in respiratory tissues, increased antibody-secreting cells in lungs and spleen, and elevated germinal center B cells and CD8+ T cell responses. Both vaccination methods reduced lung pro-inflammatory cytokines and provided full protection against lethal challenge; however, the ODF group showed lower cytokine levels, better weight maintenance, and reduced viral loads. Conclusions: ODF vaccination elicits more robust systemic and mucosal immune responses than oral vaccination and may serve as a promising alternative method of influenza vaccine delivery.Keywords
Funding Information
- the National Research Foundation of Korea (NRF) (NRF2018R1A6A1A03025124)
- Kyung Hee University (NRF2018R1A6A1A03025124)
This publication has 29 references indexed in Scilit:
- Respiratory Virus Vaccines: Pathways to Recommendations and Enhanced Coverage for At-Risk PopulationsInfectious Diseases and Therapy, 2024
- Dose sparing enabled by immunization with influenza vaccine using orally dissolving filmInternational Journal of Pharmaceutics, 2024
- Orally dissolving film as a potential vaccine delivery carrier to prevent influenza virus infectionAntiviral Research, 2024
- Influenza vaccination for elderly, vulnerable and high-risk subjects: a narrative review and expert opinionInternal and Emergency Medicine, 2023
- Advances in formulation and manufacturing strategies for the delivery of therapeutic proteins and peptides in orally disintegrating dosage formsEuropean Journal of Pharmaceutical Sciences, 2023
- Mucosal vaccine delivery: A focus on the breakthrough of specific barriersActa Pharmaceutica Sinica B, 2022
- Recent advances of oral film as platform for drug deliveryInternational Journal of Pharmaceutics, 2021
- Orodispersible films based on blends of trehalose and pullulan for protein deliveryEuropean Journal of Pharmaceutics and Biopharmaceutics, 2018
- Role of T cell immunity in recovery from influenza virus infectionCurrent Opinion in Virology, 2013
- Mucosal Delivery Routes for Optimal Immunization: Targeting Immunity to the Right Tissues2010